×

Flow resistance modulated aerosolized active agent delivery

  • US 8,408,200 B2
  • Filed: 10/07/1999
  • Issued: 04/02/2013
  • Est. Priority Date: 10/09/1998
  • Status: Expired due to Fees
First Claim
Patent Images

1. A device for controlling the delivery of an aerosolized active agent to the lungs of a human patient, said device comprising a valve that provides a high flow resistance of at least 0.4 (cm H2O)1/2/SLM in the inhalation direction at the onset of the patient'"'"'s inhalation and that subsequently opens during the inhalation to provide a lower flow resistance, wherein the lower flow resistance allows for a higher flow rate through the device.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×